ilShinBioBase Co

ilShinBioBase Co Equity Ratio

The Equity Ratio of ilShinBioBase Co (068330.KQ) as of Oct 21, 2026 is 94.48 %. In the previous year, Equity Ratio was 94.54 % — a change of -0.07% (lower).

Equity Ratio

94.48 %

YoY

-0.07%

Last updated:

Equity Ratio of ilShinBioBase Co is 2025 94.48 % . Equity Ratio of ilShinBioBase Co was 2024 94.54 % . It decreases by -0.07% lower compared to the previous year.

The ilShinBioBase Co Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
90.35 KRW
Jan 1, 2019
88.02 KRW
Jan 1, 2020
89.57 KRW
Jan 1, 2021
88.81 KRW
Jan 1, 2022
92.08 KRW
Jan 1, 2023
94.14 KRW
Jan 1, 2024
94.54 KRW
Jan 1, 2025
94.48 KRW
The ilShinBioBase Co Equity Ratio history
YEAREquity RatioYoY
94.48 %-0.07%
94.54 %+0.43%
94.14 %+2.24%
92.08 %+3.68%
88.81 %-0.85%
89.57 %+1.76%
88.02 %-2.58%
90.35 %-1.26%
91.50 %+4.47%
87.58 %+6.57%
82.19 %-4.19%
85.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ilShinBioBase Co Stock analysis

What does ilShinBioBase Co do? ilShinbiobase Co., Ltd. generates revenue by manufacturing and distributing industrial refrigeration equipment. Its product portfolio includes freeze dryers for drying sera, antibiotics, enzymes, laboratory samples, and foods; programmable freeze dryers for early-stage research with temperature, time, and vacuum control; deep freezers for biotechnology applications; and ice makers for research laboratories. The company also offers blood bank refrigerators, pharmaceutical refrigerators, shakers, and food processing equipment. These products are sold domestically and to overseas markets, targeting biotechnology firms, pharmaceutical companies, research institutions, and laboratories requiring specialized refrigeration solutions. The company's revenue streams primarily come from the sale of its industrial refrigeration equipment to customers in the biotechnology, pharmaceutical, and research sectors. Products like programmable freeze dryers and deep freezers are specifically designed for early-stage research and biotechnology applications, catering to the needs of laboratories and biotech firms. Blood bank refrigerators and pharmaceutical refrigerators serve healthcare and pharmaceutical industries, while ice makers and food processing equipment support research and food-related applications. ilShinbiobase’s business model focuses on providing specialized refrigeration equipment for niche markets. The company targets biotechnology and pharmaceutical industries with deep freezers and blood bank refrigerators, while programmable freeze dryers and shakers are marketed to research laboratories. Overseas and domestic distribution channels ensure market reach, with products tailored to specific industry requirements such as serum drying in pharmaceuticals and sample preservation in laboratories. ilShinBioBase Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ilShinBioBase Co stock

Equity Ratio of ilShinBioBase Co is 94.48 % in 2025.

Equity Ratio of ilShinBioBase Co changed from 94.54 % to 94.48 %, representing a -0.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio ilShinBioBase Co since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's ilShinBioBase Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — ilShinBioBase Co

All Key Metrics — ilShinBioBase Co